RxDoctor Payments Data

Donald Stewart, MD

Foot and Ankle Surgery · Arlington, TXNPI 1851592224

Payments from drug & device makers

What this record shows

The money is spread across several categories — other (43.0%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Linvatec Corporation at 43.0% of the total. Reporting peaked in 2022 at $25,897 and has fallen 60.8% since, to $10,161 in 2025. Among foot and ankle surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$60,600in general payments, 2019–2025

Across 146 payments — averaging $415.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Linvatec Corporation$26K
  • Smith+Nephew$14K
  • Treace Medical Concepts, Inc.$10K
  • Pylant Medical$4K
  • Stryker$3K
  • Arthrex$3K
  • plus $899 from 13 others

What the payments were for

  • Consulting fees$7,65013%
  • Speaking & faculty fees$13,60622%
  • Travel & lodging$4,5748%
  • Food & beverage$4,1717%
  • Education$4,5167%
  • Other$26,08243%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$60,600 in reported general payments places this provider in the 90th percentile of 684 foot and ankle surgery providers in Texas.

See all foot and ankle surgery providers in Texas

Medicare billing

Part B allowed, 2024
$132,179
Medicare patients
333
Services billed
1,389

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib52$1,178
Meloxicam406$1,122
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen70$598
Naproxen62$527
Ondansetron Hcl65$195
Gabapentin16$168
Tramadol Hcl11$38

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Arlington

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →